Anxiety News and Research

Latest Anxiety News and Research

Self-medication is key reason for prescription drug abuse in docs

...

5 Oct 2013

Report: Doctors who abuse prescription drugs often do so for "self-medication"

Doctors who abuse prescription drugs often do so for "self-medication"—whether for physical or emotional pain or stress relief, reports a study in the October Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

5 Oct 2013

Dietary modifications can reduce gastroparesis in diabetes patients

Many diabetes patients suffer from symptoms such as nausea, vomiting and lack of appetite. A doctoral thesis from the Sahlgrenska Academy shows that a diet consisting of foods that fall apart easily, for example boiled potatoes and fish gratin, can help alleviate the condition.

5 Oct 2013

Autism Speaks launches the Preclinical Autism Consortium for Therapeutics

Autism Speaks, the world's leading autism science and advocacy organization, today announced the launch of the Preclinical Autism Consortium for Therapeutics (PACT).

4 Oct 2013

Penn Medicine receives $12M NIHM grant for genetics study that points causes of mental illness

A major international consortium co-led by Penn Medicine has received a $12 million National Institute of Mental Health (NIHM) grant for a large-scale genetics study investigating why patients with chromosome 22q11.2 deletion syndrome have an increased risk of schizophrenia and other psychiatric disorders.

4 Oct 2013

CHOP’s 22q and You Center plays major role in brain and behavior consortium

Genetics experts from The Children's Hospital of Philadelphia (CHOP) are among the top leaders of a major international collaboration researching why patients with chromosome 22q11.2 deletion syndrome have an elevated risk of schizophrenia and other psychiatric illnesses.

4 Oct 2013

Two 90-minute group sessions in high schools reduce mental health problems in teens

The incidence of mental health issues amongst 509 British youth was reduced by 25 to 33% over the 24 months following two 90-minute group therapy sessions, according to a study led by Dr. Patricia Conrod of the University of Montreal and its affiliated Sainte-Justine Hospital Research Centre.

4 Oct 2013

Comorbid anxiety warns of bipolar psychotherapy need

Comorbid anxiety may flag those patients with bipolar depression who are in particular need of intensive psychotherapy, suggest findings from the Systematic Treatment Enhancement Program for Bipolar Disorder.

3 Oct 2013

Adolescent psychotic experiences lack uniformity

Psychotic experiences in adolescence appear to be quite distinct and vary widely from individual to individual, study findings indicate.

3 Oct 2013

AASM: Chronic disease sufferers must seek sleep evaluation

A new study by the Centers for Disease Control and Prevention links too little sleep (six hours or less) and too much sleep (10 or more hours) with chronic diseases -- including coronary heart disease, diabetes, anxiety and obesity -- in adults age 45 and older.

2 Oct 2013

Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

A study published today in the American Journal of Psychiatry suggests an association between smoking during pregnancy and increased risk for developing bipolar disorder in adult children.

2 Oct 2013

Multiple aspects to severe bipolar mixed states

Researchers have identified four subgroups of severe bipolar mixed states, characterized by distinct symptomatologic presentations.

1 Oct 2013

First Edition: October 1, 2013

Today's headlines detail how the federal government has been shutdown as a result of the ongoing congressional battle over the health law. Still, even as House and Senate lawmakers were unable to overcome this issue to reach a deal to provide funding to continue government operations, Oct. 1 is still the official launch of the overhaul's online insurance marketplaces.

1 Oct 2013

Use of psychotropic prescription medications in very young children stabilizing

The use of psychotropic prescription medications to treat ADHD, mood disorders, anxiety and other mental health disorders in very young children appears to have leveled off.

30 Sep 2013

New treatment methods aim to help people reduce binge-eating behavior

Two new treatment methods under investigation at Drexel University aim to help people reduce binge-eating behavior.

30 Sep 2013

Research on bone-derived hormone could lead to new treatments for memory loss, depression

Researchers from Columbia University Medical Center (CUMC) have found that the skeleton, acting through the bone-derived hormone osteocalcin, exerts a powerful influence on prenatal brain development and cognitive functions such as learning, memory, anxiety, and depression in adult mice.

27 Sep 2013

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Astellas Pharma US, Inc. and Medivation, Inc. today announced results of a national survey of men with advanced prostate cancer and caregivers of men with advanced prostate cancer.

26 Sep 2013

Researchers identify molecular pathway linking ICU ventilation to brain damage

At least 30 percent of patients in intensive care units (ICUs) suffer some form of mental dysfunction as reflected in anxiety, depression, and especially delirium. In mechanically-ventilated ICU patients, the incidence of delirium is particularly high, about 80 percent, and may be due in part to damage in the hippocampus, though how ventilation is increasing the risk of damage and mental impairment has remained elusive.

25 Sep 2013

Breastfeeding and personality: an interview with Dr Amy Brown

In the UK we've got quite a problem with breastfeeding. The government recommends that all women should breastfeed for six months, exclusively just breast milk, and then for up to a year and beyond. But quite a few women struggle in the UK. About 80% initiate breastfeeding but that drops off really quickly.

24 Sep 2013

Quartette tablets now available in U.S. for prevention of pregnancy

Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.

24 Sep 2013